pharmaphorum

FEBRUARY 26, 2021

Healthcare organisations that have been traditionally slow to adopt new technology produced a response to the pandemic that was almost in line with less regulated industries, according to a new report. Findings of research from the cloud communications platform Twilio based on 2,500 enterprise decision makers, including 117 healthcare organisations, showed it took 36 days on average to accelerate a digital transformation strategy.

Communication 128

Communication 128

Druggist

FEBRUARY 24, 2021

Haemorrhoids (haemorrhoids), also known as piles, is a common condition that causes rectal symptoms. Today I will review the best haemorrhoids treatment in the UK. I will discuss the best haemorrhoids treatment over the counter in the UK (part one) and prescription-only options to treat piles (part 2). . Summary: . What are haemorrhoids? . Symptoms of haemorrhoids.

Clinic Management 96

Clinic Management 96

Outsourcing Pharma

FEBRUARY 24, 2021

A leader from Praxis explains how the firm worked with Moderna on patient recruitment strategy and other solutions in the road to launching a vaccine.

Vaccines 78

Vaccines 78

Pharma Times

FEBRUARY 26, 2021

Edison Accelerator to support start-ups to develop AI applications for healthcare

57

57

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

FEBRUARY 22, 2021

As part of our Patients Insights series, the founder and CEO of Motherhood Understood shares her experience of postpartum depression, talks about the power of peer support, and explains what the wider healthcare community could do to play their part. Within days of giving birth to her first child, Jen Schwartz’s fairy tale view of motherhood lay in tatters at the foot of the bed she found it impossible to leave.

Hospitals 122

Hospitals 122

Pharma Marketing Network

FEBRUARY 26, 2021

Clinical is under the microscope. As the world focuses its lens on pharma, the opportunity and pressure is there to found a new era of agile, patient-centric clinical trials. Long-standing barriers to innovation are falling, digital transformation is accelerating, and new cultures in collaboration, and patient-centricity are rapidly growing. The conversations that are re-shaping the future of clinical are happening as we speak, Reuters Events Clinical 2021 is the new meeting place for US and EU

52

52

Pharma Times

FEBRUARY 22, 2021

Services will be offered to staff who have been affected by the COVID-19 pandemic

57

57

pharmaphorum

FEBRUARY 26, 2021

Rare diseases impact between 3.5%-5.9% of the world’s population. For Rare Disease Day, RBW Consulting’s Emma Thorp discusses why the consultancy is taking revenue earned from its rare disease clients and using it to fund research into the mental health impact of a rare disease diagnosis. Rare diseases are often chronic and life-threatening, and with a large percentage of cases presenting in young children, a diagnosis has a profound and unique impact on everyone affected.

Hospitals 117

Hospitals 117

Pharma Marketing Network

FEBRUARY 26, 2021

As markets swell with digital content and HCPs become increasingly time-poor, your customer engagement strategy can no longer be driven by reach and frequency, but by the value added at every interaction and touchpoint. At Pharma Customer Engagement Europe (20-22 April, Virtual) leaders unite to develop hybrid field force models, measure true digital effectiveness, and optimize content to make holistic customer engagement the norm and surpass HCP needs.

52

52

Outsourcing Pharma

FEBRUARY 25, 2021

The deal consolidates two significant players in the contract research organization arena, in a deal reportedly worth approximately $12b USD.

72

72

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

FEBRUARY 24, 2021

Biotech company will be dedicated to accelerating development of potential treatment

55

55

pharmaphorum

FEBRUARY 25, 2021

How has rare disease care changed over the last few years? And what might we expect from the next five? We attended the Rare Disease Day Virtual Parliamentary Event to find out. The rare disease community has a golden opportunity to transform the way care is delivered across all four UK nations – that’s according to speakers at a parliamentary reception held to mark 2021’s Rare Disease Day.

Documentation 111

Documentation Labelling 111

Pharma Mirror

FEBRUARY 25, 2021

Borja Guerra has been appointed new Sales & Service Director of Romaco Kilian in Cologne. The Romaco facilities in Bologna and Karlsruhe likewise have new Sales Directors: Massimiliano Cesarini and Ralph Augenstein. Romaco Kilian GmbH in Cologne has acquired a new Sales & Service Director. As of February 2021, Borja Guerra is responsible not only for the Sales & Service department but also for product and project management at the manufacturer of tablet presses for the pharmaceutical

52

52

Outsourcing Pharma

FEBRUARY 25, 2021

A leader from the genetics diagnostic solutions company explains how putting the patient first can make the difference in orphan drug development.

65

65

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

FEBRUARY 24, 2021

Over 31,000 women in London to be offered the at-home tests

54

54

pharmaphorum

FEBRUARY 25, 2021

Pfizer/BioNTech’s mRNA vaccine against COVID is a technical marvel – but the ultra-cool temperatures required for storage and stability has been tricky to handle. Maryland, US-based company Altimmune is among the biotechs and research labs trying to find more convenient alternatives and believes a nasal vaccine spray that is stable at room temperature could be the answer.

Vaccines 111

Vaccines Immunization 111

Pharma Mirror

FEBRUARY 23, 2021

SOMERSET, N.J. and GOSSELIES, BELGIUM — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based in Gosselies, Belgium, today announced that they have entered into a final and definitive agreement whereby Catalent will acquire 100% of th

52

52

Outsourcing Pharma

FEBRUARY 23, 2021

The US Food and Drug Administration (FDA) has issued guidance for companies developing vaccines, diagnostics and therapeutics against new variants of SARS-CoV-2.

Vaccines 59

Vaccines FDA 59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

FEBRUARY 23, 2021

Cell and Gene Therapy Catapult report also found a surge in the number of commercially sponsored trials

53

53

pharmaphorum

FEBRUARY 24, 2021

2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Spain. Higher biosimilar savings. Spain, like many European countries, have seen biosimilars as a route to helping manage pressure on health care spending.

Immunization 100

Immunization 100

McCreadie Group

FEBRUARY 22, 2021

February 2021 | Scott McCreadie, PharmD, MBA | Founder, President and CEO Not unlike for everyone else, 2020 was an eventful year for the McCreadie Group, and it changed a number of aspects of how we do business. I would like to reflect on one of the biggest changes we made: transitioning to a virtual company. The post Reflections on Becoming a Virtual Company appeared first on McCreadie Group Blog.

52

52

Outsourcing Pharma

FEBRUARY 24, 2021

An executive from the clinical trial technology provider will share how direct data capture can save time, avoid errors and improve the patient experience.

59

59

Pharma Times

FEBRUARY 24, 2021

Orphan designation granted for the treatment of retinitis pigmentosa and Leber Congenital amaurosis

52

52

pharmaphorum

FEBRUARY 25, 2021

To help pharma companies understand what life is really like for patients with a rare disease, a new resource has been released to coincide with Rare Disease Day 2021. A series of stakeholder interviews have been collected in a new video from Bedrock Healthcare Communications and Origins Insights that explores the underappreciated challenges of living with a rare disease.

Communication 97

Communication 97

Pharma Marketing Network

FEBRUARY 26, 2021

Look around – what do you see? Empowered patients, remote monitoring and care, platform technologies, personalized and preventative health, AI, machine learning and advanced analytics, virtual engagement, decentralized trials, telehealth, cell and gene therapy commercialization… the list goes on. Pharma is undergoing a period of unrivaled change.

40

40

Outsourcing Pharma

FEBRUARY 24, 2021

The annual event, moved to the virtual realm thanks to COVID-19, offers content on remote monitoring, drug development technology and other key topics.

56

56

Pharma Times

FEBRUARY 22, 2021

Decision made in consultation with the FDA following disappointing trial results

FDA 48

FDA 48

pharmaphorum

FEBRUARY 26, 2021

UCB and Microsoft have announced a multi-year strategic collaboration to advance the digitalisation of the Belgian pharma company and accelerate its research efforts. The companies have already been working together on the COVID Moonshot Project, which aimed to create an orally available antiviral to combat the SARS-CoV-2 coronavirus. UCB completed six months’ worth of computational screening and compound design in three days using the technology.

Compounding 97

Compounding 97

Med Ed 101

FEBRUARY 24, 2021

Parkinson’s disease (PD) has long presented challenges in medication delivery. A staple in more advanced disease control, carbidopa-levodopa requires multiple daily dosing with supratherapeutic levels leading to dyskinesias and subtherapeutic concentrations leading to troublesome “off” time. Sinemet (carbidopa-levodopa), Sinemet Controlled-Release (CR), and their respective generic equivalents have been used in PD for decades, but leave […].

Medication Delivery 40

Medication Delivery 40

Outsourcing Pharma

FEBRUARY 23, 2021

The pharma firm is partnering with the decentralized research organization on a Phase III trial testing a long-acting antibody combination treatment.

56

56

Pharma Times

FEBRUARY 25, 2021

The prestigious Clinical Researcher of the Year – The Americas has now opened its doors for entry, continuing the successes of the 10th anniversary last year.

48

48

pharmaphorum

FEBRUARY 23, 2021

The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG – is ten years old, and that milestone prompts reflections on what has worked well and what needs reform. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Germany. .

Insurance 90

Insurance Medical Records 90

Med Ed 101

FEBRUARY 21, 2021

Doxepin is a tricyclic antidepressant first approved for the treatment of depression in 1969 by the FDA. Tricyclic antidepressants are famous for their anticholinergic adverse effects including sedation and have been replaced by better-tolerated medications as first-line agents for depression. Doxepin pharmacodynamics helps determine what indications it may be beneficial for.

FDA 40

FDA 40